ChosenMed successfully closed a Series C2 financing, raising several hundred million RMB from YiJing Capital, with participation from Linzhuo Industry Fund and other leading institutions. CEC Capital Group served as the exclusive financial advisor in
SyMap Medical recently announced the successful financing of nearly $100 million from VMS Group and Primavera Capital, with participation from SiMiao Capital and HongShan Capital. CEC Capital Group served as the exclusive financial advisor in this tra
Brain Doctor Group (BDG), China's first physician group to establish a specialized brain hospital, announced today the closing of a RMB 200 million Series C financing. Led by Sequoia China, t
Beijing Changmugu Medical Technology Co., Ltd. (referred to as 'Changmugu'), a leading provider of integrated intelligent surgical solutions for orthopedics, announced the closing of a RMB 540 million Series B financing. The funding was jointly led by CIC
Beijing Bio-Bank Corporation ("Bio-Bank"), a biopharmaceutical company specializing in large molecule drug development, announced the successful closing of a hundred million RMB Series A financing, led by CDH Investments. CEC Capital served as the exclus
Shanghai BiOligo Biotech Co., Ltd. (referred to as "BiOligo"), a leading supplier of in vitro diagnostics and nucleic acid drug raw materials, recently closed a RMB 300 million Series A financing. The funding was led by The Carlyle Group, a global leading
On September 26th, Peak Sports, a leading sports brand in China, announced a strategic investment of nearly RMB 1.5 billion from China Resources Guodiao Xiamen Consumption Fund, with participation from several state-owned fund companies such as CCB Trust
Xinyi Information Technology, a provider of Internet of Things (IoT) intelligent terminal system SoC chips, recently closed nearly RMB 500 million in its Series B financing. The funds will primarily be used to strengthen chip research and development, imp
OrbusNeich Medical Group Limited ("OrbusNeich"), a global leader in vascular intervention devices, recently announced it successfully raised $200 million, led by Shenzhen Capital Group, with participation from CCB International, Star River Capital, Wanhui